These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of palmitoylation of cysteine 415 in functional coupling CB Oddi S; Totaro A; Scipioni L; Dufrusine B; Stepniewski TM; Selent J; Maccarrone M; Dainese E Biotechnol Appl Biochem; 2018 Jan; 65(1):16-20. PubMed ID: 28722168 [TBL] [Abstract][Full Text] [Related]
3. Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling. Oddi S; Dainese E; Sandiford S; Fezza F; Lanuti M; Chiurchiù V; Totaro A; Catanzaro G; Barcaroli D; De Laurenzi V; Centonze D; Mukhopadhyay S; Selent J; Howlett AC; Maccarrone M Br J Pharmacol; 2012 Apr; 165(8):2635-51. PubMed ID: 21895628 [TBL] [Abstract][Full Text] [Related]
4. Interplay between Membrane Curvature and Cholesterol: Role of Palmitoylated Caveolin-1. Krishna A; Sengupta D Biophys J; 2019 Jan; 116(1):69-78. PubMed ID: 30579563 [TBL] [Abstract][Full Text] [Related]
5. Palmitoylation of Claudin-5 Proteins Influences Their Lipid Domain Affinity and Tight Junction Assembly at the Blood-Brain Barrier Interface. Rajagopal N; Irudayanathan FJ; Nangia S J Phys Chem B; 2019 Feb; 123(5):983-993. PubMed ID: 30629442 [TBL] [Abstract][Full Text] [Related]
6. Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes. Yang W; Di Vizio D; Kirchner M; Steen H; Freeman MR Mol Cell Proteomics; 2010 Jan; 9(1):54-70. PubMed ID: 19801377 [TBL] [Abstract][Full Text] [Related]
7. Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments. Stornaiuolo M; Bruno A; Botta L; La Regina G; Cosconati S; Silvestri R; Marinelli L; Novellino E Sci Rep; 2015 Oct; 5():15453. PubMed ID: 26482099 [TBL] [Abstract][Full Text] [Related]
8. The extracellular domain of angulin-1 and palmitoylation of its cytoplasmic region are required for angulin-1 assembly at tricellular contacts. Oda Y; Sugawara T; Fukata Y; Izumi Y; Otani T; Higashi T; Fukata M; Furuse M J Biol Chem; 2020 Mar; 295(13):4289-4302. PubMed ID: 32079676 [TBL] [Abstract][Full Text] [Related]
9. Position of Proline Mediates the Reactivity of S-Palmitoylation. Khanal N; Pejaver V; Li Z; Radivojac P; Clemmer DE; Mukhopadhyay S ACS Chem Biol; 2015 Nov; 10(11):2529-36. PubMed ID: 26255674 [TBL] [Abstract][Full Text] [Related]
10. Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. Sarnataro D; Grimaldi C; Pisanti S; Gazzerro P; Laezza C; Zurzolo C; Bifulco M FEBS Lett; 2005 Nov; 579(28):6343-9. PubMed ID: 16263116 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol modulates the structure, binding modes, and energetics of caveolin-membrane interactions. Sengupta D J Phys Chem B; 2012 Dec; 116(50):14556-64. PubMed ID: 23199331 [TBL] [Abstract][Full Text] [Related]
12. Palmitoylation at Cys595 is essential for PECAM-1 localisation into membrane microdomains and for efficient PECAM-1-mediated cytoprotection. Sardjono CT; Harbour SN; Yip JC; Paddock C; Tridandapani S; Newman PJ; Jackson DE Thromb Haemost; 2006 Dec; 96(6):756-66. PubMed ID: 17139370 [TBL] [Abstract][Full Text] [Related]
13. Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible. Parat MO; Fox PL J Biol Chem; 2001 May; 276(19):15776-82. PubMed ID: 11278313 [TBL] [Abstract][Full Text] [Related]
14. Lateral diffusion, function, and expression of the slow channel congenital myasthenia syndrome αC418W nicotinic receptor mutation with changes in lipid raft components. Oyola-Cintrón J; Caballero-Rivera D; Ballester L; Baéz-Pagán CA; Martínez HL; Vélez-Arroyo KP; Quesada O; Lasalde-Dominicci JA J Biol Chem; 2015 Oct; 290(44):26790-800. PubMed ID: 26354438 [TBL] [Abstract][Full Text] [Related]
15. Caveolin regulates kv1.5 trafficking to cholesterol-rich membrane microdomains. McEwen DP; Li Q; Jackson S; Jenkins PM; Martens JR Mol Pharmacol; 2008 Mar; 73(3):678-85. PubMed ID: 18045854 [TBL] [Abstract][Full Text] [Related]
16. The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors. Nebane NM; Kellie B; Song ZH FEBS Lett; 2006 Oct; 580(22):5392-8. PubMed ID: 16989818 [TBL] [Abstract][Full Text] [Related]
17. Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex. Shim JY; Khurana L; Kendall DA Proteins; 2016 Apr; 84(4):532-43. PubMed ID: 26994549 [TBL] [Abstract][Full Text] [Related]
18. N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae. McCabe JB; Berthiaume LG Mol Biol Cell; 2001 Nov; 12(11):3601-17. PubMed ID: 11694592 [TBL] [Abstract][Full Text] [Related]
19. Artificial Palmitoylation of Proteins Controls the Lipid Domain-Selective Anchoring on Biomembranes and the Raft-Dependent Cellular Internalization. Uchida K; Obayashi H; Minamihata K; Wakabayashi R; Goto M; Shimokawa N; Takagi M; Kamiya N Langmuir; 2022 Aug; 38(31):9640-9648. PubMed ID: 35882009 [TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae. Santibanez JF; Blanco FJ; Garrido-Martin EM; Sanz-Rodriguez F; del Pozo MA; Bernabeu C Cardiovasc Res; 2008 Mar; 77(4):791-9. PubMed ID: 18065769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]